Home » Archives by category » Consensus (a)
Slide set | 2016 ESC/EAS Guidelines on the management of dyslipidaemias.

Slide set | 2016 ESC/EAS Guidelines on the management of dyslipidaemias.

  Slide set | 2016 ESC/EAS Guidelines on the management of dyslipidaemias. Publication in full here

American Diabetes Association |  Standards of Medical Care in Diabetes – 2017

American Diabetes Association | Standards of Medical Care in Diabetes – 2017

2016 European Guidelines on cardiovascular disease prevention in clinical practice

2016 European Guidelines on cardiovascular disease prevention in clinical practice

Published in 2016 Reference 2016 EHJ doi/10.1093/eurheartj/ehw106 The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Authors/Task Force […]

Consensus Statement of the European Atherosclerosis Society on Lipoprotein(a) as a cardiovascular risk factor

Consensus Statement of the European Atherosclerosis Society on Lipoprotein(a) as a cardiovascular risk factor

The aims of the study were, first, to critically evaluate lipoprotein(a) [Lp(a)] as a cardiovascular risk factor and, second, to advise on screening for elevated plasma Lp(a), on desirable levels, and on therapeutic strategies. Read the full article here

Consensus Statement of the European Atherosclerosis Society on Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease.

Consensus Statement of the European Atherosclerosis Society on Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease.

Abstract Objective: This EAS Consensus Panel critically appraised evidence relevant to the benefit to risk relationship of functional foods with added plant sterols and/or plant stanols, as components of a healthy lifestyle, to reduce plasma low-density lipoprotein-cholesterol (LDL-C) levels, and thereby lower cardiovascular risk. Methods and results: Plant sterols/stanols (when taken at 2 g/day) cause significant inhibition […]

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012).

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012).

The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Read here the full article.